Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 2 , Pages 151-160 , April 2009

The Role of Natriuretic Peptide Administration in Cardiovascular Surgery–Associated Renal Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Sagar U. Nigwekar, MD

      Affiliations

    • Department of Internal Medicine, Rochester General Hospital and University of Rochester School of Medicine, Rochester, NY
    • Corresponding Author InformationAddress reprint requests to Sagar U. Nigwekar, MD, Department of Internal Medicine, Rochester General Hospital, 1425 Portland Ave, Rochester, NY 14621
    • ,
  • John K. Hix, MD

      Affiliations

    • Department of Nephrology and Internal Medicine, Rochester General Hospital and University of Rochester School of Medicine, Rochester, NY

References 

  1. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19–32
  2. Hertzer NR, Mascha EJ, Karafa MT, et al. Open infrarenal abdominal aortic aneurysm repair: The Cleveland Clinic experience from 1989 to 1998. J Vasc Surg. 2002;35:1145–1154
  3. Wahlberg E, Dimuzio PJ, Stoney RJ. Aortic clamping during elective operations for infrarenal disease: The influence of clamping time on renal function. J Vasc Surg. 2002;36:13–18
  4. Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–348
  5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality (A cohort analysis). JAMA. 1996;275:1489–1494
  6. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization (The Multicenter Study of Perioperative Ischemia Research Group). Ann Intern Med. 1998;128:194–203
  7. Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158–1162
  8. Garwood S. Renal insufficiency after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8:227–241
  9. Thakar CV, Yared JP, Worley S, et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64:239–246
  10. Leacche M, Rawn JD, Mihaljevic T, et al. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol. 2004;93:353–356
  11. Bellomo R, Auriemma S, Fabbri A, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008;2:166–178
  12. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol. 2003;285:167–177
  13. Roy DR. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol. 1986;25:220–225
  14. Opgenorth TJ, Novosad EI. Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur J Pharmacol. 1990;191:351–357
  15. Sagnella GA. Practical implications of current natriuretic peptide research. J Renin Angiotensin Aldosterone Syst. 2000;1:304–315
  16. Gagelmann M, Hock D, Forssmann WG. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett. 1988;233:249–254
  17. Sonnenberg H, Honrath U, Chong CK, et al. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol. 1986;250:F963–F966
  18. Lainchbury JG, Burnett JC, Meyer D, et al. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am J Physiol Heart Circ Physiol. 2000;278:H33–H40
  19. Chen HH, Cataliotti A, Schirger JA, et al. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1093–R1097
  20. Elíasdóttir SB, Klemenzson G, Torfason B, et al. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand. 2008;52:182–187
  21. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia. 2008;63:1226–1233
  22. Kentsch M, Drummer C, Gerzer R, et al. Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure. Eur J Clin Invest. 1995;25:281–283
  23. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis (Auriculin Anaritide Acute Renal Failure Study Group). N Engl J Med. 1997;336:828–834
  24. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement (Quality of Reporting of Meta-analyses). Lancet. 1999;354:1896–1900
  25. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 1996;17:1–12
  26. Alderson P, Green S, Higgins JPT. Analysing and presenting results. 2004;Section 8, Cochrane Reviewer's Handbook 4.2.2. The Cochrane Library, Issue 1, 2004. Vol. Updated March 2004, John Wiley & Sons Ltd
  27. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  28. Sumi K, Iida H, Yamaguchi S, et al. Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy. J Cardiothorac Vasc Anesth. 2008;22:204–209
  29. Wiebe K, Meyer M, Wahlers T, et al. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN:Ularitide). Eur J Med Res. 1996;1:259–265
  30. Bergman A, Odar-Cederlöf I, Westman L, et al. Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1996;10:490–496
  31. Brackbill ML, Stam MD, Schuller-Williams RV, et al. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Ann Pharmacother. 2007;41:427–432
  32. Brenner P, Meyer M, Reichenspurner H, et al. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. Eur J Med Res. 1995;1:137–143
  33. Chen HH, Sundt TM, Cook DJ, et al. Low-dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary bypass surgery: A double-blind placebo-controlled pilot study. Circulation. 2007;116:I134–I138
  34. Hayaashi Y, Ohtani M, Sawa Y, et al. Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. J Cardiovasc Pharmacol. 2003;42:636–641
  35. Hayashida N, Chihara S, Kashikie H, et al. Effects of intraoperative administration of atrial natriuretic peptide. Ann Thorac Surg. 2000;70:1319–1326
  36. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol. 2007;49:716–726
  37. Meyer M, Wiebe K, Wahlers T, et al. Urodilatin (INN:ularitide) as a new drug for the therapy of acute renal failure following cardiac surgery. Clin Exp Pharmacol Physiol. 1997;24:374–376
  38. Mitaka C, Kudo T, Jibiki M, et al. Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair. Crit Care Med. 2008;36:745–751
  39. Sezai A, Shiono M, Orime Y, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg. 2000;69:732–738
  40. Sezai A, Hata M, Wakui S, et al. Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: Possibility of postoperative left ventricular remodeling effect. Circ J. 2006;70:1426–1431
  41. Sezai A, Shiono M, Hata M, et al. Efficacy of continuous low-dose human atrial natriuretic peptide given from the beginning of cardiopulmonary bypass for thoracic aortic surgery. Surg Today. 2006;36:508–514
  42. Sezai A, Shiono M, Wakui S, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J. 2007;71:1401–1407
  43. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med. 2004;32:1310–1315
  44. Tang IY, Murray PT. Prevention of perioperative acute renal failure: What works?. Best Pract Res Clin Anaesthesiol. 2004;18:91–111
  45. Zacharias M, Gilmore IC, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2005;3:CD003590
  46. Roasio A, Lobreglio R, Santin A, et al. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:23–26
  47. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: A meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49:56–68
  48. Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: A meta-analysis. J Cardiothorac Vasc Anesth. 2008;22:27–33
  49. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321–328
  50. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature. 1986;324:473–476
  51. Harris PJ, Thomas D, Morgan TO. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature. 1987;326:697–698
  52. Dillingham MA, Anderson RJ. Inhibition of vasopressin action by atrial natriuretic factor. Science. 1986;231:1572–1573
  53. Struthers AD. Ten years of natriuretic peptide research: A new dawn for their diagnostic and therapeutic use?. BMJ. 2004;308:1615–1619
  54. Hayashi M, Tsutamoto T, Wada A, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol. 2001;37:1820–1826
  55. Takagi G, Kiuchi K, Endo T, et al. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol. 2000;36:22–30
  56. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure (Nesiritide Study Group). N Engl J Med. 2000;343:246–253
  57. Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial (Natrecor Study Group). J Am Coll Cardiol. 1999;34:155–162
  58. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA. 2002;287:1531–1540
  59. Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure (Anaritide Acute Renal Failure Study Group). Am J Kidney Dis. 2000;36:767–774
  60. Mattson DL, Lu S, Roman RJ, et al. Relationship between renal perfusion pressure and blood flow in different regions of the kidney. Am J Physiol. 1993;264:R578–R583
  61. Riter HG, Redfield MM, Burnett JC, et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. 2006;47:2334–2335
  62. Ali ZA, Callaghan CJ, Lim E, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: A randomized controlled trial. Circulation. 2007;116(suppl):I98–I105
  63. Hashiguchi H, Morooka H, Miyoshi H, et al. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg. 2005;101:1584–1589
  64. Investigators Report New Renal, Mortality and Safety Data From NAPA Trial of NATRECOR(R) (nesiritide). http://www.medicalnewstoday.com/articles/51595.phpAccessed August 18, 2008
  65. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol. 2004;15:1597–1605
  66. Chertow GM, Palevsky PM, Greene T. Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. Clin J Am Soc Nephrol. 2006;1:1124–1127
  67. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988;
  68. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve acute kidney injury outcomes. Crit Care. 2007;11:R31
  69. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int. 2008;73:1008–1016

PII: S1053-0770(08)00353-4

doi: 10.1053/j.jvca.2008.11.007

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 2 , Pages 151-160 , April 2009

Article Tools

* Image Usage & Resolution